Log In
BCIQ
Print this Print this
 

Betalutin

  Manage Alerts
Collapse Summary General Information
Company Nordic Nanovector ASA
DescriptionLutetium-177 radiopharmaceutical conjugated to the anti-CD37 mAb lilotomab
Molecular Target CD37
Mechanism of Action 
Therapeutic ModalityBiologic

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today